GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Akums Drugs and Pharmaceuticals Ltd (BOM:544222) » Definitions » PB Ratio

Akums Drugs and Pharmaceuticals (BOM:544222) PB Ratio : 2.63 (As of Apr. 19, 2025)


View and export this data going back to 2024. Start your Free Trial

What is Akums Drugs and Pharmaceuticals PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2025-04-19), Akums Drugs and Pharmaceuticals's share price is ₹486.25. Akums Drugs and Pharmaceuticals's Book Value per Share for the quarter that ended in Dec. 2024 was ₹185.07. Hence, Akums Drugs and Pharmaceuticals's PB Ratio of today is 2.63.

Good Sign:

Akums Drugs and Pharmaceuticals Ltd stock PB Ratio (=2.35) is close to 1-year low of 2.35.

The historical rank and industry rank for Akums Drugs and Pharmaceuticals's PB Ratio or its related term are showing as below:

BOM:544222' s PB Ratio Range Over the Past 10 Years
Min: 2.35   Med: 4.63   Max: 23
Current: 2.63

During the past 4 years, Akums Drugs and Pharmaceuticals's highest PB Ratio was 23.00. The lowest was 2.35. And the median was 4.63.

BOM:544222's PB Ratio is ranked worse than
64.91% of 932 companies
in the Drug Manufacturers industry
Industry Median: 1.84 vs BOM:544222: 2.63

During the past 12 months, Akums Drugs and Pharmaceuticals's average Book Value Per Share Growth Rate was 306.20% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -6.20% per year.

During the past 4 years, the highest 3-Year average Book Value Per Share Growth Rate of Akums Drugs and Pharmaceuticals was -6.20% per year. The lowest was -6.20% per year. And the median was -6.20% per year.

Back to Basics: PB Ratio


Akums Drugs and Pharmaceuticals PB Ratio Historical Data

The historical data trend for Akums Drugs and Pharmaceuticals's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Akums Drugs and Pharmaceuticals PB Ratio Chart

Akums Drugs and Pharmaceuticals Annual Data
Trend Mar21 Mar22 Mar23 Mar24
PB Ratio
- - - -

Akums Drugs and Pharmaceuticals Quarterly Data
Mar21 Mar22 Mar23 Sep23 Dec23 Mar24 Sep24 Dec24
PB Ratio Get a 7-Day Free Trial - - - 4.52 -

Competitive Comparison of Akums Drugs and Pharmaceuticals's PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Akums Drugs and Pharmaceuticals's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Akums Drugs and Pharmaceuticals's PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Akums Drugs and Pharmaceuticals's PB Ratio distribution charts can be found below:

* The bar in red indicates where Akums Drugs and Pharmaceuticals's PB Ratio falls into.


;
;

Akums Drugs and Pharmaceuticals PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Akums Drugs and Pharmaceuticals's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Dec. 2024)
=486.25/185.072
=2.63

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Akums Drugs and Pharmaceuticals  (BOM:544222) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Akums Drugs and Pharmaceuticals PB Ratio Related Terms

Thank you for viewing the detailed overview of Akums Drugs and Pharmaceuticals's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Akums Drugs and Pharmaceuticals Business Description

Traded in Other Exchanges
Address
Akums House, Plot No. 131 to 133, Block C, Mangolpuri Industrial Area Phase1, Adjoining CBSE Office, Delhi, IND, 110083
Akums Drugs and Pharmaceuticals Ltd a pharmaceutical contract development and manufacturing organization (CDMO) offering a comprehensive range of pharmaceutical products and services in India and overseas. Its services include formulation research and development (R&D), preparation and filing of regulatory dossiers in the Indian and Outside markets, and other testing services. It is also engaged in the manufacturing and sale of branded pharmaceutical formulations and active pharmaceutical ingredients (APIs). The operates in three segments: a) Contract Development and Manufacturing Operations (CDMO), b) Active Pharmaceutical Ingredient (API), and c) Branded and Generic formulations. Key revenue is generated from Contract Development and Manufacturing Operations (CDMO).

Akums Drugs and Pharmaceuticals Headlines

No Headlines